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Accelerate Cell Culture Development Using the Modular Automated Sampling Technology 
(MASTTM) Platform in an Integrated Bioprocess Lab Environment  
 
 
ABSTRACT 
 
Biopharmaceutical companies are continually striving to fundamentally understand and 
optimize cellular performance within their bioreactors.  While on-line process analytical 
technology (PAT) tools like dielectric and Raman spectroscopy are helping to provide insight into 
cell processes that impact titer and antibody quality, the integration of these data with off-line 
measurements such as cell density, viability, titer and glycosylation remains an elusive goal.   
 
Bend Research Inc., in collaboration with Lilly, Pfizer and other major biopharmaceutical 
companies, is advancing the Modular Automated Sampling Technology (MASTTM) platform and 
integrating this system with automated analytical and data retrieval systems.  This approach 
allows application of novel experimental methods providing greater insight into the bioreactor 
environment.  In this process, aseptically collected bioreactor samples are delivered to multiple 
analytical devices with resulting data being automatically retrieved and curated.  This data is 
presented at a graphical user interface (GUI) for real-time data analysis and predictive model 
development.  Early studies with the MAST sample delivery system coupled with our data-
processing software increased system observability and real-time process understanding by the 
end user. 
 
This presentation describes how Bend Research has used the MAST platform as a cornerstone of 
an integrated lab environment.  We will describe how the MAST system works and the features 
that set it apart from other autosampling solutions.  Applications will be presented where MAST 
facilitated the use novel development approaches yielding enhance process understanding  
 
From this new level of insight into the bioreactor, scientists can obtain enhanced data-driven 
guidance for key activities like optimizing process operation.  With this new technology, the 
bioprocess industry can make major advances toward advanced real-time testing, predictive 
control, and overall enhanced bioprocess design and operation. 
 
